Status:

COMPLETED

Prognostic Value of Lactates in ICU

Lead Sponsor:

Mongi Slim Hospital

Conditions:

Mortality

Eligibility:

All Genders

18+ years

Brief Summary

he aim of this prospective, analytic trial was to evaluate the accuracy of blood lactates levels in predicting mortality in ICU patients.

Detailed Description

In this study, conducted over o 12 months period, arterial blood lactates levels were measured in ICU patients at admission (H0), every 6 hours during the first day and and H48. This trial included t...

Eligibility Criteria

Inclusion

  • All adults admissions in ICU with a predicted length of stay \> 24 hours

Exclusion

  • Patients who died during the first 24 hours after ICU admission

Key Trial Info

Start Date :

June 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 31 2020

Estimated Enrollment :

135 Patients enrolled

Trial Details

Trial ID

NCT04792736

Start Date

June 1 2019

End Date

July 31 2020

Last Update

March 11 2021

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Mongi Slim University Hospital

La Marsa, Tunis Governorate, Tunisia, 2046

2

Mongi Slim Hospital

Tunis, Tunisia, 2046

Prognostic Value of Lactates in ICU | DecenTrialz